Lozano-Edo, S.; Roselló-LletÃ, E.; Sánchez-Lázaro, I.; Tarazón, E.; Portolés, M.; Ezzitouny, M.; Lopez-Vilella, R.; Arnau, M.A.; Almenar, L.; MartÃnez-Dolz, L.
Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker. J. Pers. Med. 2022, 12, 913.
https://doi.org/10.3390/jpm12060913
AMA Style
Lozano-Edo S, Roselló-Lletà E, Sánchez-Lázaro I, Tarazón E, Portolés M, Ezzitouny M, Lopez-Vilella R, Arnau MA, Almenar L, MartÃnez-Dolz L.
Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker. Journal of Personalized Medicine. 2022; 12(6):913.
https://doi.org/10.3390/jpm12060913
Chicago/Turabian Style
Lozano-Edo, Silvia, Esther Roselló-LletÃ, Ignacio Sánchez-Lázaro, EstefanÃa Tarazón, Manuel Portolés, Maryem Ezzitouny, Raquel Lopez-Vilella, Miguel Angel Arnau, Luis Almenar, and Luis MartÃnez-Dolz.
2022. "Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker" Journal of Personalized Medicine 12, no. 6: 913.
https://doi.org/10.3390/jpm12060913
APA Style
Lozano-Edo, S., Roselló-LletÃ, E., Sánchez-Lázaro, I., Tarazón, E., Portolés, M., Ezzitouny, M., Lopez-Vilella, R., Arnau, M. A., Almenar, L., & MartÃnez-Dolz, L.
(2022). Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker. Journal of Personalized Medicine, 12(6), 913.
https://doi.org/10.3390/jpm12060913